Although it is not possible to draw conclusions about causality, these findings suggest that RSK2 is a potential biomarker in breast cancer, especially in a specific subtype of breast cancer, and might provide new perspective of the interaction between RSK2 and breast cancer. This evidence concerns the gene RPS6KA3 and breast carcinoma.